MedTrace Logo

Nationwide Assessment of Cardiovascular Risk Factors: in Chinese Patients With Type 2 Diabetes

NCT01128205 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25000

Last updated 2011-06-15

No results posted yet for this study

Summary

The objective of this study is to evaluate the level of control of cardiovascular disease risk factors, including blood pressure, blood lipid, and blood glucose, in out patients with type 2 DM in 6 representative regions in China: Northeast, North, East, South, Southwest and Northwest, measured by,

1. Proportion of patients reaching adequate control of blood glucose
2. Proportion of patients reaching adequate control of blood glucose and blood pressure, or blood glucose and blood lipid
3. Proportion of patients reaching adequate control of all 3Bs, i.e. blood glucose, blood pressure, and blood lipid.

Conditions

Sponsors & Collaborators

  • Merck Sharp & Dohme LLC

    collaborator INDUSTRY

  • China Gerontological Society

    collaborator OTHER

  • VitalStrategic Research Institute

    collaborator OTHER

  • China Cardiometabolic Registries

    lead NETWORK

Principal Investigators

  • Linong Ji, MD · Peking University People's Hospital

  • Dayi Hu, MD · Peking University People's Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-06-30
Primary Completion
2011-06-30
Completion
2011-06-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01128205 on ClinicalTrials.gov